Summary
Eli Lillys Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lillys GLP-1 drugs for wei
Source: ConsumerAffairs
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
